1. Targeting Chemokines and Chemokine GPCRs to Enhance Strong Opioid Efficacy in Neuropathic Pain
   Martina Vincenzi et al, 2022, Life CrossRef
2. Microglial inflammation modulates opioid analgesic tolerance
   Priyanka Pahan et al, 2023, Journal of Neuroscience Research CrossRef
3. Targeting Cytokines for Morphine Tolerance: A Narrative Review
   Dai-Qiang Liu et al, 2019, Current Neuropharmacology CrossRef
4. Endogenous opiates and behavior: 2017
   Richard J. Bodnar, 2020, Peptides CrossRef
5. Low‑affinity neurotrophin receptor p75 of brain‑derived neurotrophic factor contributes to cancer‑induced bone pain by upregulating mTOR signaling
   Xiao‑Wen Meng et al, 2019, Experimental and Therapeutic Medicine CrossRef
6. Optimization and In Vivo Profiling of a Refined Rat Model of Walker 256 Breast Cancer Cell-Induced Bone Pain Using Behavioral, Radiological, Histological, Immunohistochemical and Pharmacological Methods
   Priyank Shenoy et al, 2017, Frontiers in Pharmacology CrossRef
7. Targeting the chemokine ligand 2–chemokine receptor 2 axis provides the possibility of immunotherapy in chronic pain
   Shan Liu et al, 2023, European Journal of Pharmacology CrossRef
8. Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder
   Jennifer R. Schroeder et al, 2018, Psychopharmacology CrossRef
9. Effect of stress hyperglycaemia on monocyte chemoattractant protein‑1 levels and the short‑term prognosis of patients with acute ST‑segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
   Nina Liu et al, 2019, Experimental and Therapeutic Medicine CrossRef